133 related articles for article (PubMed ID: 1698933)
1. Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells.
Nonaka G; Nishioka I; Nishizawa M; Yamagishi T; Kashiwada Y; Dutschman GE; Bodner AJ; Kilkuskie RE; Cheng YC; Lee KH
J Nat Prod; 1990; 53(3):587-95. PubMed ID: 1698933
[TBL] [Abstract][Full Text] [Related]
2. Anti-AIDS agents, 1. Isolation and characterization of four new tetragalloylquinic acids as a new class of HIV reverse transcriptase inhibitors from tannic acid.
Nishizawa M; Yamagishi T; Dutschman GE; Parker WB; Bodner AJ; Kilkuskie RE; Cheng YC; Lee KH
J Nat Prod; 1989; 52(4):762-8. PubMed ID: 2478667
[TBL] [Abstract][Full Text] [Related]
3. New hydrolyzable tannins, shephagenins A and B, from Shepherdia argentea as HIV-1 reverse transcriptase inhibitors.
Yoshida T; Ito H; Hatano T; Kurata M; Nakanishi T; Inada A; Murata H; Inatomi Y; Matsuura N; Ono K; Nakane H; Noda M; Lang FA; Murata J
Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1436-9. PubMed ID: 8795264
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
5. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
[TBL] [Abstract][Full Text] [Related]
6. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of erythro-9(2-hydroxy-3-nonyl) adenine (EHNA) on HIV-1 production in vitro.
Sei Y; Inoue M; Tsuboi I; Yokoyama MM; Arora PK
Biochem Biophys Res Commun; 1989 Oct; 164(1):345-50. PubMed ID: 2478129
[TBL] [Abstract][Full Text] [Related]
8. Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs.
Huang L; Kashiwada Y; Cosentino LM; Fan S; Chen CH; McPhail AT; Fujioka T; Mihashi K; Lee KH
J Med Chem; 1994 Nov; 37(23):3947-55. PubMed ID: 7525962
[TBL] [Abstract][Full Text] [Related]
9. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
Ichimura H; Levy JA
Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
[TBL] [Abstract][Full Text] [Related]
10. The proteinase inhibitor pepstatin A inhibits formation of reverse transcriptase in H9 cells infected with human immunodeficiency virus 1.
Grinde B; Hungnes O; Tjøtta E
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):269-74. PubMed ID: 2471542
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
Balzarini J; Karlsson A; Sardana VV; Emini EA; Camarasa MJ; De Clercq E
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6599-603. PubMed ID: 7517553
[TBL] [Abstract][Full Text] [Related]
12. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo.
Notka F; Meier G; Wagner R
Antiviral Res; 2004 Nov; 64(2):93-102. PubMed ID: 15498604
[TBL] [Abstract][Full Text] [Related]
13. MAP 30: a new inhibitor of HIV-1 infection and replication.
Lee-Huang S; Huang PL; Nara PL; Chen HC; Kung HF; Huang P; Huang HI; Huang PL
FEBS Lett; 1990 Oct; 272(1-2):12-8. PubMed ID: 1699801
[TBL] [Abstract][Full Text] [Related]
14. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents.
Kashiwada Y; Hashimoto F; Cosentino LM; Chen CH; Garrett PE; Lee KH
J Med Chem; 1996 Mar; 39(5):1016-7. PubMed ID: 8676334
[No Abstract] [Full Text] [Related]
15. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro.
Vonsover A; Loya S; Sredni B; Albeck M; Gotlieb-Stematsky T; Araf O; Hizi A
AIDS Res Hum Retroviruses; 1992 May; 8(5):613-23. PubMed ID: 1381205
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus.
Notka F; Meier GR; Wagner R
Antiviral Res; 2003 Apr; 58(2):175-86. PubMed ID: 12742578
[TBL] [Abstract][Full Text] [Related]
18. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus.
Schinazi RF; Chu CK; Babu JR; Oswald BJ; Saalmann V; Cannon DL; Eriksson BF; Nasr M
Antiviral Res; 1990 May; 13(5):265-72. PubMed ID: 1697740
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor.
Priel E; Showalter SD; Blair DG
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):65-72. PubMed ID: 1707642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
